학술논문
A phase I study of LY3009120, a pan-RAF inhibitor, in patients with advanced or metastatic cancer
Document Type
Article
Author
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, February 2020, 19(2):460-467)
Subject
Language
English
ISSN
15388514
15357163
15357163